Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Wolfe

Showing results (151-160 of 195) with videos related to

Pageof 20
Sort By:
Frontiers in Public Health|May 12, 2025
A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severitySarah Dewilde, Cynthia Z Qi, Femke De Ruyck, et al.
Muscle & Nerve|January 5, 2006
Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravisShin J Oh, Yuki Hatanaka, Shoji Hemmi, et al.
Neurology|September 25, 1999
Brachial amyotrophic diplegia: a slowly progressive motor neuron disorderJ S Katz, G I Wolfe, P B Andersson, et al.
JAMA Network Open|April 13, 2026
Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia GravisJoseph Lord, Matthew Walton, Peter Murphy, et al.
JAMA Neurology|February 15, 2013
Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sampleRobert W Haley, Elizabeth Charuvastra, William E Shell, et al.
Muscle & Nerve|July 17, 2015
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trialMichael Benatar, Michael P Mcdermott, Donald B Sanders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Surveillance of transmitted HIV drug resistance using matched plasma and dried blood spot specimens from voluntary counseling and testing sites in Ho Chi Minh City, Vietnam, 2007-2008Nguyen Bui Duc, Bui Thu Hien, Nick Wagar, et al.
Muscle & Nerve|September 22, 2025
Reply to the Letter to the Editor: The Role of Patient-Reported Symptoms in Standardizing MGFA Class 0 and MGFA-PISKatherine Ruzhansky, Yuebing Li, Gil I Wolfe, et al.
Muscle & Nerve|April 22, 2025
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task ForceKatherine Ruzhansky, Yuebing Li, Gil I Wolfe, et al.
Advances in Therapy|October 29, 2024
Risk-Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia GravisA Gordon Smith, Gil I Wolfe, Ali A Habib, et al.
Pageof 20

Showing results (151-160 of 195) with videos related to

Sort By:
Pageof 20
Frontiers in Public Health|May 12, 2025
A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severitySarah Dewilde, Cynthia Z Qi, Femke De Ruyck, et al.
Muscle & Nerve|January 5, 2006
Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravisShin J Oh, Yuki Hatanaka, Shoji Hemmi, et al.
Neurology|September 25, 1999
Brachial amyotrophic diplegia: a slowly progressive motor neuron disorderJ S Katz, G I Wolfe, P B Andersson, et al.
JAMA Network Open|April 13, 2026
Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia GravisJoseph Lord, Matthew Walton, Peter Murphy, et al.
JAMA Neurology|February 15, 2013
Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sampleRobert W Haley, Elizabeth Charuvastra, William E Shell, et al.
Muscle & Nerve|July 17, 2015
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trialMichael Benatar, Michael P Mcdermott, Donald B Sanders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Surveillance of transmitted HIV drug resistance using matched plasma and dried blood spot specimens from voluntary counseling and testing sites in Ho Chi Minh City, Vietnam, 2007-2008Nguyen Bui Duc, Bui Thu Hien, Nick Wagar, et al.
Muscle & Nerve|September 22, 2025
Reply to the Letter to the Editor: The Role of Patient-Reported Symptoms in Standardizing MGFA Class 0 and MGFA-PISKatherine Ruzhansky, Yuebing Li, Gil I Wolfe, et al.
Muscle & Nerve|April 22, 2025
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task ForceKatherine Ruzhansky, Yuebing Li, Gil I Wolfe, et al.
Advances in Therapy|October 29, 2024
Risk-Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia GravisA Gordon Smith, Gil I Wolfe, Ali A Habib, et al.
Pageof 20